Immunomedics' $40M Deal Over Data Scandal Gets Initial OK

By Katryna Perera (February 23, 2023, 10:26 PM EST) -- A New Jersey federal judge granted preliminary approval on Thursday to a $40 million settlement between pharmaceutical company Immunomedics Inc. and a class of its investors that will resolve claims that the company and several of its top brass failed to disclose a data integrity breach attributed to workers at one of its drug manufacturing facilities that led to the rejection of one of its highly valuable drugs by the U.S. Food and Drug Administration....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!